Dr. George Zervos, MD

Dr. Zervos practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Zervos' NPI, 1487702544, was assigned on January 8, 2007. Dr. Zervos graduated from Carol Davila University of Medicine and Pharmacy in 1980. Dr. Zervos holds New York license 170701.

Dr. Zervos' primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Dr. Zervos' primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Zervos to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zervos practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zervos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zervos is licensed in New York.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Zervos treats.

CMS data shows 1,939 Medicare services from Dr. Zervos across 9 procedure codes in 2024, for 437 Medicare patients. Medicare paid $170,548 for them.

CMS counts 437 Medicare patients who saw Dr. Zervos in 2024. The largest group is 75 to 84, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zervos' median patient age at 64, with 50% women.

In 2024, Dr. Zervos wrote 266 Medicare Part D claims for 65 patients. 47% of them were for generic drugs. CMS names the drug for 156 of them, across 8 drugs with 11 or more claims each, at $1,617,718 in total drug cost. In 2023, CMS named 81 claims across 5 drugs.

Dr. Zervos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Zervos to 1 clinical trial. Conditions studied include Hemoglobinuria, Paroxysmal and Anemia, Hemolytic. Open Payments lists research payments to Dr. Zervos that name 1 trial.

CMS Open Payments shows 366 general payments to Dr. Zervos from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,329. It also lists 3 research payments totaling $1,950 in 2016, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Zervos, most recently CMS Stage 1 2012 in 2012.

Dr. Zervos graduated from Carol Davila University of Medicine and Pharmacy in 1980.

Dr. Zervos is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.